Collin Jasper C.
Pachingel BSN 2C4
Drug name Dosages Therapeutic actions Indications
rifaximin (Rx) 200mg Rifaximin inhibits Hepatic
Brand and Other 550mg bacterial RNA encephalopathy: Reduction
Names:Xifaxan Administration synthesis by binding in the risk of overt hepatic
Classes: to bacterial DNA- encephalopathy recurrence
• Antibiotics, Oral: Administer with dependent RNA in adults.
Other; or without food. polymerase.
• Antidiarrheals Irritable bowel syndrome
without
constipation: Treatment of
moderate to severe irritable
bowel syndrome without
constipation in adults.
Travelers'
diarrhea: Treatment of
travelers' diarrhea caused
by noninvasive strains
of Escherichia coli in adults
and pediatric patients ≥12
years of age.
Limitations of use: Rifaximin
should not be used in
patients with diarrhea
complicated by fever or
blood in the stool or diarrhea
caused by pathogens other
than E. coli.
Adverse effects Contraindications Nursing considerations
Headache (10%) Hypersensitivity to Assessment & Drug Effects
Rectal tenesmus (7%) rifaximin, other
Abdominal pain (7%) rifamycin antibiotics, • Withhold drug and
Defecation urgency (6%) or any component of notify physician if
Nausea (5%) the formulation symptoms worsen or
Constipation (4%) last >48 h after
Pyrexia (3%) starting drug; an
Vomiting (2%) alternative treatment
should be
considered.
• Report promptly the
appearance of blood
in the stool.
Patient & Family Education
• Report promptly any
of the following: fever;
difficulty breathing;
skin rash, itching, or
hives; worsening
diarrhea during or
after treatment or
blood in the stool.
• Do not breast feed
while taking this drug
without consulting
physician.
Classification: Dosage: ● Hypersensitivity Side effects: Intervention/Evaluation:
5ml/amp Erceflora contributes immune system
Antidiarrheals to therecovery of the to B.clausii or to ● Shake the drug
● Acute diarrhea any of the product disorders before
Route: intestinalmicrobial with duration of hypersensitivity
Brand name: flora altered during excipients administration
Erceflora PO <14 days due to reactions (rashes) ● Use only a
the course of infection, drugsor Adverse effects: minimal
Frequency: microbial poisons. • Not for use in No adverse effects
Generic: Bacillus disorders of diverse dose for
Q4 ● Chronic or immuno- were noted in clinical
clausii origin. Itproduces minimal
persistent diarrhea compromised trials of B. clausii or in
various vitamins, periods.
with durationof >14 patients the product
particularly group B ● Do not exceed its
days. such as cancer information
vitaminsthus recommended dose.
patients on
contributing to ● Monitor the
chemothera
correction of vitamin patient for
py andpatients
disorders caused unusual effects
taking
byantibiotics fromthe drug.
immunosuppressive
& ● Administer the
medications
chemotherapeutic drug within 30
agents. Italso minutes after
promotes opening the
normalization of container/ampule.
intestinal flora.
Patient/Family Teaching:
● Educate the
patient and
family about the
uses and
recommended
dose of the drug.
● Educate the
patient and
family about
thepossible
side effects of
the medication.
● Encourage family
to report unusual
effects and
changes of the
patient’s condition
upon
 administration.
Educate the patient and
family to avoidalcohol intake
after taking the drug.

Aminoleban 1-3 packets of given to restore the Given to balance the Patients with myopathy, Hypersensitivity Before beginning treatment,
Aminoleban a day, plasma's normal levels plasma's amino acids, carbs, hypopotassemia, and evaluate the patient's
Parenteral Nutritional of amino acids, lipids, vitamins, and aldosteronism should not Rare skin condition. Be mindful of
Product carbohydrates, lipids, minerals. use this medication. eruptions detrimental impact Observe
vitamins, and the temperature.
minerals. individuals GI: occasional
with chronic liver nausea and
disease, especially vomiting
those who have Others: If Gastrointestinal symptoms
hepatic Occasional arise, keep an eye on the
encephalopathy, chills, fever
patient's hydration.
should get nutritional and headache.
supplementation
Lactulose 20ml-BID By creating an osmotic diarrhea and salmonellosis Individuals with GI: Initial dose may Evaluate the patient's lifestyle
impact in the colon and Hepatic encephalopathy gastrotestinal blockage, cause flatulence, in relation to fluid intake, body
Classification: resulting distention, treatment galactosemia, or belching, stomach mass, and activity, as well as
Hyperosmoticlaxative lactulose encourages disaccharide deficiency who cramps, discomfort, their ammonia level (30-70
peristalsis. It lessens require a low-lactose diet and distention; mg/100 mL) and mental state
the absorption of excessive amount on a regular basis. This patient
harmful nitrogenous may cause diarrhea; has hepatic encephalopathy.
chemicals and nausea, vomiting, and
ammonium ions in hydrogen gas buildup Keep an eye out for any
hepatic in the colon. potential Gastrointestinal
encephalopathy, reactions.
which lowers the blood
ammonia content.
urine output: track hydration
and electrolyte status
Repamipide The dose of this Repamipide, a PUD and stomach mucosal Hypersensitivity Rash, itching, and
medicine will be mucosal protective lesions in acute and chronic drug-induced eczema. observe the Gastrointestinal
Classification: different for different agent, is thought to gastritis are treated together symptom for improvement
Antacids,Antireflux patients improve prostaglandin with anti-secretory GI: Occasionally, dry
&Antiulcerant production, boost medicines. NSAID-induced mouth, constipation,
gastric blood flow, and gastropathy prevention. feeling like your
reduce free oxygen stomach is growing,
radicals. diarrhea, nausea, and CBC evaluation for liver
vomiting function tests

Identify constipation

Keep an eye on the electrolyte

levels as necessary.